Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. - Wikidata - awgldk - TriplyDB

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.

http://www.wikidata.org/entity/Q36493992

about

Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions Scaling-up malaria treatment: a review of the performance of different providers Improved malaria case management through the implementation of a health facility-based sentinel site surveillance system in Uganda The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial Tracking the quality of care for sick children using lot quality assurance sampling: targeting improvements of health services in Jigawa, Nigeria Interrupting transmission of soil-transmitted helminths: a study protocol for cluster randomised trials evaluating alternative treatment strategies and delivery systems in Kenya Guidelines in lower-middle income countries.Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.Malaria treatment policy change in Uganda: what role did evidence play?Towards achieving Abuja targets: identifying and addressing barriers to access and use of insecticides treated nets among the poorest populations in Kenya.Provider attitudes toward the voluntary medical male circumcision scale-up in Kenya, South Africa, Tanzania and Zimbabwe.Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016 What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism."…still waiting for chloroquine": the challenge of communicating changes in first-line treatment policy for uncomplicated malaria in a remote Kenyan district.Barriers to prompt and effective malaria treatment among the poorest population in Kenya The quest for universal access to effective malaria treatment: how can the AMFm contribute?Do health workers' preferences influence their practices? Assessment of providers' attitude and personal use of new treatment recommendations for management of uncomplicated malaria, Tanzania.Changes in health workers' malaria diagnosis and treatment practices in Kenya.Exploring provider and community responses to the new malaria diagnostic and treatment regime in Solomon Islands.Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.Treatment of uncomplicated malaria at public health facilities and medicine retailers in south-eastern Nigeria.Quality of care for the treatment for uncomplicated malaria in South-East Nigeria: how important is socioeconomic status?Taking stock: provider prescribing practices in the presence and absence of ACT stock.Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.Management of uncomplicated malaria in children under 13 years of age at a district hospital in Senegal: from official guidelines to usual practices.Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries Malaria treatment policy change and implementation: the case of Uganda.Knowledge, Attitudes, and Practices about Malaria and Its Control in Rural Northwest Tanzania.Prescription practices and availability of artemisinin monotherapy in India: where do we stand?Provider compliance to artemisinin-based combination therapy at primary health care facilities in the middle belt of Ghana.Mind the gap: knowledge and practice of providers treating uncomplicated malaria at public and mission health facilities, pharmacies and drug stores in Cameroon and Nigeria.Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol The implementation of a new Malaria Treatment Protocol in Timor-Leste: challenges and constraints.Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.The effect of an anti-malarial subsidy programme on the quality of service provision of artemisinin-based combination therapy in Kenya: a cluster-randomized, controlled trial.

P2860

Q17485067-C9427583-8F5C-4F78-9DAF-51A8497CC511 Q21034143-33E89C9D-4268-4C9A-B873-58CF007471EA Q26823767-1BD347B6-BD89-4691-AB4D-ABB3F7C77AC1 Q28476776-7D39FA44-80EA-45D7-87B6-03651CE9079C Q28478353-42217C2F-7694-4486-94D4-AC1D8F91BB2C Q28484091-CDF08D61-2F13-460B-9DDC-447B972714A9 Q28610530-B8530209-DF74-4A10-90FC-27AAA43A7E56 Q30235270-06F9E0C8-0248-47E6-A1DC-E60F1C8D2E93 Q30396834-B8EE474D-11EA-42BB-8462-41B412241442 Q30586992-EE345219-7B67-4F92-BBA5-3D3CF0C94D38 Q33541270-CADB29D6-5DC2-4F99-A156-5CA105A75B78 Q33572665-BCBF56D0-5B44-4EFF-8375-D9BEDC3892D1 Q33601120-CD404355-C2BA-4BB0-89BA-F9031D55FCDD Q33604549-515D2EA9-6398-488D-B49B-5FE55F906A1A Q33909114-1C4E6542-526D-4AA5-A6F4-A09A7570AA8F Q33942446-A22C0081-D4A3-4E3D-BF6B-568DC567ACDC Q34221877-ABB33B04-B4BC-426C-8CCD-A641DB5410C3 Q34471175-52D7C01F-5DBA-4016-BBED-66D331ED5D99 Q34499550-A961479D-669D-4EBF-B017-993E894CDE13 Q34504063-E849D2DE-FEEE-4E86-A0B1-AA0874165C46 Q34559398-6404D1A8-9F65-45CF-9609-2699601CCEB1 Q34805334-B8728E85-BBF5-497F-847B-B746296F1650 Q35030048-0F1A47D8-35C3-455C-A5B9-2818D105174A Q35061349-A2C341A8-F235-4D6F-8692-77534D3F0462 Q35089702-96CC419F-DC45-4D65-B6F1-C43FE7D53BA5 Q35185058-B05D7332-B619-4706-82CC-379B53C60861 Q35198733-D803DBC4-418B-4CD1-8A89-710811904569 Q35299140-1796D3F8-25D3-4F64-A2B8-4D00663BD573 Q35478040-F443ABB8-48BA-4251-8F5A-72DE457D2373 Q35570396-546613DF-649E-4B98-A3CB-9479A61DE95E Q35692263-F84A3C8B-113C-4736-885A-5BD4379DCF8F Q35746267-2983691C-1872-4DA2-9F38-FCE4F8F6C5ED Q35768911-F57B5FD8-B720-4E71-9879-9B1B93355BA2 Q36082548-91BD094B-2D3F-4012-A289-E85EBE2207DC Q36133716-BD9BF33A-8F4A-4F0C-83A7-CF5A445C1B20 Q36232163-0F96A74A-A395-4AB4-A350-8B27A3F15201 Q36443296-A65D0DD2-5ADA-4A07-AB01-93BEA1C63A23 Q36531312-78468FE0-6BDD-49DE-8A21-513C3EF340FC Q36724458-534D65B5-EECF-45E9-AF5A-DCD9D93E0618 Q36734979-023F279D-9912-48F4-A0DA-78C981EAFE7F

P2860

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.

http://www.wikidata.org/entity/Q36493992

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Why don't health workers presc ...... on of artemether-lumefantrine.

@ast

Why don't health workers presc ...... on of artemether-lumefantrine.

@en

type

label

Why don't health workers presc ...... on of artemether-lumefantrine.

@ast

Why don't health workers presc ...... on of artemether-lumefantrine.

@en

prefLabel

Why don't health workers presc ...... on of artemether-lumefantrine.

@ast

Why don't health workers presc ...... on of artemether-lumefantrine.

@en

P1433

Q36493992-A72E8041-388B-4649-8FA8-24AA7862A91A

P1476

Q36493992-23F7B166-C102-4F15-B69D-CD1FF9D3C0AD

P2093

Q36493992-B3EFA4B6-B515-4571-861E-6936BB4259F8

Q36493992-C96AE4AA-9D92-4A0C-9C5B-20BDB4DF5A31

Q36493992-E293971F-E0E3-4A24-8C85-C62F11DAF635

P2860

Q36493992-02CB3A07-23DD-4386-9D73-375FEF6F6451

Q36493992-04BC5C42-28FA-4193-A15E-9411A355148F

Q36493992-0DD3B98B-C392-469E-B849-66B38181B99A

Q36493992-1C5F4380-417D-4085-A66F-A450B1CAB8BC

Q36493992-1F0FD41B-4C14-4EB8-8CF2-B80A0DD740FD

Q36493992-2FB3AAA1-DA2D-4D86-98F8-74474E757CBB

Q36493992-3308EF80-6806-421A-9A65-49C6144A8CD8

Q36493992-35185488-7FE1-4DA2-82AC-B1E79790E05D

Q36493992-47B1170E-E9C7-44B9-8FFC-57CA0C69B896

Q36493992-48F033BB-3728-4B79-8886-F703E35B90A3

P2888

Q36493992-55DCD598-4C3A-4BE1-88EF-74CA8104D832

P304

Q36493992-9DF2CEF8-1901-4BED-A3C9-C107279EBFC5

P31

Q36493992-61989447-43B4-4866-8AF7-B908B4125916

P356

Q36493992-27548A90-F6D8-4852-A843-D8CE84A3A90E

P478

Q36493992-EEA469F0-7325-477C-94C2-98CF374D152B

P50

Q36493992-A0ABA268-1B3C-4A05-9757-D55147DBCDEC

P577

Q36493992-C2FB201E-B2D8-4EA5-B788-90DE0F449FE6

P5875

Q36493992-D5E7B533-DD3F-410E-9103-711532469321

P6179

Q36493992-84BE88DA-9613-4559-B18E-9D1798751BCA

P698

Q36493992-859165D3-F1FA-4598-AAF9-34F630C6EF85

P932

Q36493992-413F526E-6778-4A36-8F9B-92F2151557F5

P356

P1433

Malaria Journal

P1476

Why don't health workers presc ...... on of artemether-lumefantrine.

@en

P2093

Beatrice Wasunna

http://www.w3.org/2001/XMLSchema#string

Catherine A Goodman

http://www.w3.org/2001/XMLSchema#string

Dejan Zurovac

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.

Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya.

Diabetes in Africa. Challenges to health care for diabetes in Africa.

Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study.

Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.

The process of changing national malaria treatment policy: lessons from country-level studies.

Antimalarial prescribing practices: a challenge to malaria control in Ghana.

The quality of sulfadoxine-pyrimethamine prescriptions, counselling and drug-dispensing practices, for children in Kenya

Quality of treatment for febrile illness among children at outpatient facilities in sub-Saharan Africa.

P2888

P304

29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-7-29

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5600279

http://www.w3.org/2001/XMLSchema#string

P6179

1027840052

http://www.w3.org/2001/XMLSchema#string

P698

18252000

http://www.w3.org/2001/XMLSchema#string

P932

2266770

http://www.w3.org/2001/XMLSchema#string